Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. CL
stocks logo

CL

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
5.03B
-0.56%
0.896
-1.57%
5.16B
+2.52%
0.911
+0.14%
5.16B
+4.46%
0.942
+3.52%
Estimates Revision
The market is revising Upward the revenue expectations for Colgate-Palmolive Company (CL) for FY2025, with the revenue forecasts being adjusted by 0.97% over the past three months. During the same period, the stock price has changed by -2.89%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.97%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.94%
In Past 3 Month
Stock Price
Go Down
down Image
-2.89%
In Past 3 Month
14 Analyst Rating
up Image0
Wall Street analysts forecast CL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CL is 101.15 USD with a low forecast of 86.00 USD and a high forecast of 110.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
4 Hold
1 Sell
Moderate Buy
up Image0
Current: 87.780
sliders
Low
86.00
Averages
101.15
High
110.00
up Image0
Current: 87.780
sliders
Low
86.00
Averages
101.15
High
110.00
UBS
Peter Grom
Strong Buy
Maintains
$105 → $109
2025-04-17
Reason
UBS
Peter Grom
Price Target
$105 → $109
2025-04-17
Maintains
Strong Buy
Reason
Barclays
Lauren Lieberman
Hold
Maintains
$89 → $86
2025-04-11
Reason
Barclays
Lauren Lieberman
Price Target
$89 → $86
2025-04-11
Maintains
Hold
Reason
JP Morgan
Andrea Teixeira
Buy
Maintains
$99 → $95
2025-04-11
Reason
JP Morgan
Andrea Teixeira
Price Target
$99 → $95
2025-04-11
Maintains
Buy
Reason
JPMorgan lowered the firm's price target on Colgate-Palmolive to $95 from $99 and keeps an Overweight rating on the shares as part of a Q1 preview for the beverage, household and personal care products group. Consumption has been decelerating in developed markets in particular, in the U.S. and most recently in Western Europe, the analyst tells investors in a research note. The firm says that while the Q1 earnings results will not matter per se, it thinks investors will start to shift to stock picking based on forward looking commentary. The sector is broadly more defensive versus most stocks against tariffs, but some companies have sourcing from the most impacted regions, in particular China, contends JPMorgan.
Wells Fargo
Chris Carey
Sell
Maintains
$83 → $88
2025-04-02
Reason
Wells Fargo
Chris Carey
Price Target
$83 → $88
2025-04-02
Maintains
Sell
Reason
Piper Sandler
Korinne Wolfmeyer
Buy
Maintains
$108 → $107
2025-03-31
Reason
Piper Sandler
Korinne Wolfmeyer
Price Target
$108 → $107
2025-03-31
Maintains
Buy
Reason
Piper Sandler lowered the firm's price target on Colgate-Palmolive to $107 from $108 on slightly lower forward estimates and an unchanged 29-turns 2025 price-to-earnings multiple. The firm keeps an Overweight rating on the shares following a recent catch-up with Colgate-Palmolive and investor conversations exiting Q1.
Barclays
Lauren Lieberman
Hold
Maintains
$83 → $89
2025-03-27
Reason
Barclays
Lauren Lieberman
Price Target
$83 → $89
2025-03-27
Maintains
Hold
Reason
Barclays raised the firm's price target on Colgate-Palmolive to $89 from $83 and keeps an Equal Weight rating on the shares. Ahead of Q1 earnings, the firm revisited estimates across beverages and consumer products to account for slower consumer demand in the U.S. among other headwinds.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Colgate-Palmolive Co (CL.N) is 24.72, compared to its 5-year average forward P/E of 24.70. For a more detailed relative valuation and DCF analysis to assess Colgate-Palmolive Co 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
24.70
Current PE
24.72
Overvalued PE
26.23
Undervalued PE
23.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
16.21
Current EV/EBITDA
16.04
Overvalued EV/EBITDA
17.06
Undervalued EV/EBITDA
15.35

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
3.66
Current PS
3.59
Overvalued PS
3.98
Undervalued PS
3.33

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

CL News & Events

Events Timeline

(ET)
2025-06-12
06:02:34
ICE raids have pushed many Latino shoppers into hiding, WSJ says
select
link
2025-05-29 (ET)
2025-05-29
16:32:08
Colgate-Palmolive names Prabha Parameswaran vice chair
select
2025-04-25 (ET)
2025-04-25
09:45:15
Colgate-Palmolive sees $200M gross impact to costs from tariffs
select
Sign Up For More Events
Sign Up For More Events

News

Preview
8.0
06-18NASDAQ.COM
Interesting CL Put And Call Options For February 2026
  • Put Contract Analysis: The $85.00 put contract for Colgate-Palmolive offers a premium of $2.45, allowing investors to potentially buy shares at an effective cost of $82.55, representing a 3% discount from the current price, with a 64% chance of expiring worthless and yielding a 2.88% return on cash commitment.

  • Call Contract Insights: The $90.00 call contract has a bid of $3.70, providing a potential total return of 6.43% if exercised, while also having a 48% chance of expiring worthless, which would yield an additional 4.20% return, highlighting the importance of analyzing trading history and fundamentals.

Preview
3.0
06-17NASDAQ.COM
CL Quantitative Stock Analysis - Warren Buffett
  • Colgate-Palmolive Company Analysis: Colgate-Palmolive (CL) received a 68% rating from Validea's Patient Investor model, which is based on Warren Buffett's strategy focusing on firms with predictable profitability and low debt.

  • Warren Buffett Overview: Warren Buffett, chairman of Berkshire Hathaway, is renowned as one of the greatest investors, known for his modest lifestyle and consistent market outperformance over decades.

Preview
4.5
06-17NASDAQ.COM
CLX's Productivity Drive: Likely to Aid Margins & Offset High Costs?
  • Clorox Company’s Productivity Initiatives: Clorox is enhancing its operational efficiency through digital tools and an ERP conversion, aiming for higher productivity and margin expansion despite facing inflationary pressures. The company has reported a 240 basis point increase in gross margin year-over-year in Q3 fiscal 2025.

  • Industry Competitors' Strategies: Colgate-Palmolive, Procter & Gamble, and Newell Brands are also focusing on productivity improvements and strategic investments to navigate inflation and enhance margins, with each company implementing unique initiatives to bolster their operational capabilities and market performance.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Colgate-Palmolive Co (CL) stock price today?

The current price of CL is 87.78 USD — it has decreased -0.46 % in the last trading day.

arrow icon

What is Colgate-Palmolive Co (CL)'s business?

Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.

arrow icon

What is the price predicton of CL Stock?

Wall Street analysts forecast CL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CL is 101.15 USD with a low forecast of 86.00 USD and a high forecast of 110.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Colgate-Palmolive Co (CL)'s revenue for the last quarter?

Colgate-Palmolive Co revenue for the last quarter amounts to 4.91B USD, decreased -3.04 % YoY.

arrow icon

What is Colgate-Palmolive Co (CL)'s earnings per share (EPS) for the last quarter?

Colgate-Palmolive Co. EPS for the last quarter amounts to 0.85 USD, increased 2.41 % YoY.

arrow icon

What changes have occurred in the market's expectations for Colgate-Palmolive Co (CL)'s fundamentals?

The market is revising Upward the revenue expectations for Colgate-Palmolive Company (CL) for FY2025, with the revenue forecasts being adjusted by 0.97% over the past three months. During the same period, the stock price has changed by -2.89%.
arrow icon

How many employees does Colgate-Palmolive Co (CL). have?

Colgate-Palmolive Co (CL) has 34000 emplpoyees as of June 23 2025.

arrow icon

What is Colgate-Palmolive Co (CL) market cap?

Today CL has the market capitalization of 71.14B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free